Davide Campari-Milano N.V. (CPR) — Stock analysis

Campari Group produce y comercializa bebidas espirituosas premium en todo el mundo. Sus marcas más conocidas son Campari (amargo), Aperol (aperitivo), Wild Turkey (bourbon americano), Grand Marnier (licor francés) y Espolòn Tequila.

Campari cotiza en Borsa Italiana con el ticker CPR. Es componente del índice FTSE MIB.

Sí. Distribuye un pequeño dividendo anual. La rentabilidad es habitualmente del 0,5-1%, baja por decisión propia: la empresa prefiere reinvertir la caja en adquisiciones de nuevas marcas y expansión geográfica.

Acquisition-led growth is a core part of Campari's strategy: rather than paying out most of its cash as dividends, it has historically reinvested to buy brands (such as Grand Marnier and Wild Turkey) and to take control of its distribution in key markets. That is why its dividend yield is modest. Whether that trade-off suits you is your call — Lucex explains the strategy, it does not recommend the stock.

Common areas to examine include organic sales growth, gross and operating margins, net debt (acquisitions are often debt-funded), and the geographic mix of sales. Lucex brings these together in plain language around the position you hold — as information, never as advice.